Homburger acted as counsel to UBS Switzerland as mandated lead arranger, agent, security agent and original lender in connection with the financing of the acquisition of iTS Swiss Kanal Services (formerly ISS Kanal Services) by
Tags :News
As per her latest LinkedIn update, Esther Van Weert (pictured), the former head of compliance at Roche has been named as head of ethics and compliance at Galderma, a global dermatology company. Van Weert will
Bär & Karrer acted as legal advisors to CVC on its contribution to the funding received by Acronis, the global operator in cyber protection, for more than 250 million USD. Acronis received the funding from
Nestlé Health Science have entered into an agreement with Nuun, a leader in functional hydration, in which Nestlé Health Science will acquire Nuun. The acquisition complements Nestlé Health Science’s existing broad portfolio of active
A team of CMS Switzerland and CMS Italy led by Stefan Brunnschweiler advised Nahrin on all legal aspects of the acquisition of the Italy based Swisscare from Alcedo IV and the two founding shareholders Stelvio
Borel & Barbey acted as legal advisors for Alpian on the structuring and execution of its Series B fundraising of around CHF 17 million. On this transaction Borel & Barbey team was led by Luca Bozzo (
Borel & Barbey acted as legal advisors for Swissroc Investment on the acquisition of an industrial and logistics real estate portfolio of five properties in Switzerland. The transaction, totaling nearly 50 million CHF (including upcoming CAPEX),
Roxana Bollinger-Bär entered into Cms Switzerland private client team. Bollinger-Bär specializes in domestic and cross-border wealth and succession planning as well as estate litigation. She represents clients in inheritance disputes before courts as
Bratschi advised PHT International, as Swiss local counsel in the acquisition of all shares of PHT Pharmaceutical formerly known as BPh Investitionen. For this transaction, Bratschi team was led by Florian S. Jörg (pictured),
Walder Wyss acted as legal counsel to Swiss Life on the placement of CHF 250 million perpetual subordinated bond, first callable in September 2026 and a CHF 250 million dated subordinated bond with final maturity in 2041, and with
